F002 - Atopic Dermatitis in Adults: Not Just Big Kids
Friday, March 1; 9:00 AM - 11:00 AM
Following this course, the attendee should be able to:
- Describe the various presentations and differential diagnosis of atopic dermatitis in adults
- Identify key differences between atopic dermatitis in children and adults
- Discuss treatment considerations for atopic dermatitis in adults
This session will review the diagnosis and unique aspects of atopic dermatitis in adults. Key subjects to be covered include differences of epidemiology, genetics, phenotype, comorbidities, clinical course and response to topical and systemic treatment of atopic dermatitis in adults as compared with children.
- Silverberg, Jonathan I., MD, PhD, MPH: AbbVie – C(H), I(NC); AnaptysBio – C(H); Asana Biosciences, LLC – C(H); Dermira – A(H); Eli Lilly and Company – C(H), I(NC); Galderma Research & Development, LLC – C(H); GlaxoSmithKline – C(H), I(NC); Glenmark Generics Inc. – C(H); Kiniksa Pharmaceuticals, Ltd. – C(H), I(NC); Leo Pharma Inc – A(H); Leo Pharma Inc. – I(H); Medimmune – C(H); Menlo Therapeutics – A(H), I(NC); Pfizer Inc. – A(H), C(H); Regeneron – C(H), I(NC), SP(H); Sanofi – C(Grants/Research Funding);